Cargando…
Developing Picornaviruses for Cancer Therapy
Oncolytic viruses (OVs) form a group of novel anticancer therapeutic agents which selectively infect and lyse cancer cells. Members of several viral families, including Picornaviridae, have been shown to have anticancer activity. Picornaviruses are small icosahedral non-enveloped, positive-sense, si...
Autores principales: | McCarthy, Cormac, Jayawardena, Nadishka, Burga, Laura N., Bostina, Mihnea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562951/ https://www.ncbi.nlm.nih.gov/pubmed/31100962 http://dx.doi.org/10.3390/cancers11050685 |
Ejemplares similares
-
Correction: McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685
por: McCarthy, Cormac, et al.
Publicado: (2020) -
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
por: Jayawardena, Nadishka, et al.
Publicado: (2019) -
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
por: Jayawardena, Nadishka, et al.
Publicado: (2020) -
Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus
por: Jayawardena, Nadishka, et al.
Publicado: (2018) -
N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection
por: Jayawardena, Nadishka, et al.
Publicado: (2021)